Engineered Bacterial Outer Membrane Vesicles Remodel Tumor Microenvironment for Enhanced Photodynamic Immunotherapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Chaofan Nie und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Flexible Electronics (LoFE), Xi'an Institute of Flexible Electronics, and Xi'an Institute of Biomedical Materials and Enginee…. Hauptthemen laut MEDLINE: Photochemotherapy, Tumor Microenvironment, Immunotherapy, Bacterial Outer Membrane. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi, Shaanxi Provincial Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Tumor immunotherapy harnesses the immune system to recognize and eliminate tumor cells, offering notable advantages of precise targeting and sustained antitumor responses. However, the immunosuppressive tumor microenvironment (TME) often limits the monotherapy effectiveness, resulting in immune evasion and treatment resistance. Moreover, various therapeutic agents capable of modulating the TME suffer from poor aqueous solubility and severe systemic toxicity. In this study, an engineered nanotherapeutic platform, PN@OMVs, is prepared by co‐encapsulating the photosensitizer pheophorbide a (PPa) and the indoleamine 2,3‐dioxygenase 1 (IDO1) inhibitor NLG919 within Escherichia coli BL21‐derived outer membrane vesicles (OMVs). In a murine bilateral subcutaneous CT26 colon cancer model, PN@OMVs markedly enhanced systemic antitumor immunity through the synergistic effects of OMV‐incorporated pathogen‐associated molecular patterns (PAMPs) and photodynamic therapy‐induced immunogenic cell death, increasing dendritic cell maturation from 2.77% to 19.84%. Meanwhile, PN@OMVs significantly inhibited IDO1 activity, disrupted the tryptophan‐kynurenine metabolic pathway, and diminished regulatory T cell infiltration within tumor tissues, thereby reversing the immunosuppressive TME. Most importantly, a single administration combined with light irradiation could achieve tumor inhibition rates of 92.3% in primary tumors and 83.1% in distant tumors, without observable systemic toxicity. This study presents a promising paradigm of developing engineered OMVs to effectively remodel the TME for enhanced immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Flexible Electronics (LoFE), Xi'an Institute of Flexible Electronics, and Xi'an Institute of Biomedical Materials and Engineering, Northwestern Polytechnical University, Xi'an, China.
- Queen Mary University of London Engineering School, Northwestern Polytechnical University, Xi'an, China.
- Henan Institute of Flexible Electronics (HIFE) and School of Flexible Electronics, Henan University, Zhengzhou, China.
ORCID-Profile: Peng Li
Förderung
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi
- Shaanxi Provincial Science Fund for Distinguished Young Scholars
- Fundamental Research Funds for the Central Universities, China
Zitieren
APA
Nie, C., Wang, P., Wang, J., Zhou, Z., Yang, L., Zhang, X., Feng, T., & Li, P. (2026). Engineered Bacterial Outer Membrane Vesicles Remodel Tumor Microenvironment for Enhanced Photodynamic Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504869
Vancouver
Nie C, Wang P, Wang J, Zhou Z, Yang L, Zhang X, et al. Engineered Bacterial Outer Membrane Vesicles Remodel Tumor Microenvironment for Enhanced Photodynamic Immunotherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504869
BibTeX
@article{Nie2026,
author = {Nie, Chaofan and Wang, Peiren and Wang, Junru and Zhou, Zijian and Yang, Liu and Zhang, Xia and Feng, Tao and Li, Peng},
title = {Engineered Bacterial Outer Membrane Vesicles Remodel Tumor Microenvironment for Enhanced Photodynamic Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504869}
}
EUVIMED